Robotic Duodenal Switch Is Associated with Outcomes Comparable to those of Laparoscopic Approach.


Journal

Obesity surgery
ISSN: 1708-0428
Titre abrégé: Obes Surg
Pays: United States
ID NLM: 9106714

Informations de publication

Date de publication:
May 2021
Historique:
received: 16 09 2020
accepted: 29 12 2020
revised: 20 12 2020
pubmed: 20 1 2021
medline: 20 4 2021
entrez: 19 1 2021
Statut: ppublish

Résumé

This study evaluates the outcomes of robotic duodenal switch (RDS) when compared to conventional laparoscopy (LDS). Using the Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program (MBSAQIP), patients who underwent RDS were compared to those of LDS (2015-2018) for perioperative characteristics and thirty-day postoperative outcomes. Operative complexity, complications, and resource utilization trends were plotted over the included years for the two approaches. Multivariable analysis was conducted to characterize the impact of each approach on these outcomes. Of 7235 minimally invasive operations, 5720 (79.1%) were LDS while 1515 (20.9%) were RDS. Intraoperative endoscopy, anastomosis testing, and shorter operative duration were associated with LDS. RDS group had more concomitant procedures with less attending assistance. The odds ratios of organ space infection and sepsis were equivalent. RDS increased the odds ratios for venous thromboembolism [VTE] (odds ratio [OR] = 2.3, 95% confidence interval [CI] = 1.1-4.8, p = 0.02) and early discharge (OR = 7.3, CI = 4.9-10.9, p < 0.01). The difference in wound infection between LDS and RDS has been decreasing (1.5% and 1.5% in 2018 from 2.3% and 4.1% in 2015, respectively) over the years. Similarly, the decreasing trends were noted for systemic infections. While the development of VTE after RDS was higher, most of the other complications were comparable between LDS and RDS in this study. RDS may reduce the need for advanced intraoperative assistance and minimize hospital stay in select cases, without increasing morbidity. The recent trends suggest a gradual decrease in the variations between LDS and RDS outcomes over time.

Identifiants

pubmed: 33462669
doi: 10.1007/s11695-020-05198-5
pii: 10.1007/s11695-020-05198-5
pmc: PMC7813533
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2019-2029

Références

Prachand VN, Davee RT, Alverdy JC. Duodenal switch provides superior weight loss in the super-obese (BMI > or =50 kg/m2) compared with gastric bypass. Ann Surg. 2006;244(4):611–9.
pubmed: 16998370 pmcid: 1856567
Buchwald H, Kellogg TA, Leslie DB, et al. Duodenal switch operative mortality and morbidity are not impacted by body mass index. Ann Surg. 2008;248(4):541–8.
doi: 10.1097/SLA.0b013e318188e1c2
Wittgrove AC, Clark GW, Tremblay LJ. Laparoscopic gastric bypass, Roux-en-Y: preliminary report of five cases. Obes Surg. 1994;4(4):353–7.
doi: 10.1381/096089294765558331
Nguyen NT, Ho HS, Palmer LS, et al. A comparison study of laparoscopic versus open gastric bypass for morbid obesity. J Am Coll Surg. 2000;191(2):149–55. discussion 155–7
doi: 10.1016/S1072-7515(00)00276-3
DeMaria EJ, Pate V, Warthen M, et al. Baseline data from American Society for Metabolic and Bariatric Surgery-designated Bariatric Surgery Centers of Excellence using the Bariatric Outcomes Longitudinal Database. Surg Obes Relat Dis. 2010;6(4):347–55.
doi: 10.1016/j.soard.2009.11.015
Rogula T, Koprivanac M, Janik MR, et al. Does robotic Roux-en-Y Gastric bypass provide outcome advantages over standard laparoscopic approaches? Obes Surg. 2018;28(9):2589–96.
doi: 10.1007/s11695-018-3228-6
Hagen ME, Pugin F, Chassot G, et al. Reducing cost of surgery by avoiding complications: the model of robotic Roux-en-Y gastric bypass. Obes Surg. 2012;22(1):52–61.
doi: 10.1007/s11695-011-0422-1
Dapri G, Cadière GB, Himpens J. Laparoscopic conversion of adjustable gastric banding and vertical banded gastroplasty to duodenal switch. Surg Obes Relat Dis. 2009;5(6):678–83.
doi: 10.1016/j.soard.2009.07.001
Sudan R, Puri V, Sudan D. Robotically assisted biliary pancreatic diversion with a duodenal switch: a new technique. Surg Endosc. 2007;21(5):729–33.
doi: 10.1007/s00464-006-9171-y
Kim W, Gagner M, Kini S, et al. Laparoscopic vs. open biliopancreatic diversion with duodenal switch: a comparative study. J Gastrointest Surg. 2003;7(4):552–7. https://doi.org/10.1016/S1091-255X(02)00149-X .
doi: 10.1016/S1091-255X(02)00149-X pubmed: 12763415
Sudan R, Podolsky E. Totally robot-assisted biliary pancreatic diversion with duodenal switch: single dock technique and technical outcomes. Surg Endosc. 2015;29(1):55–60.
doi: 10.1007/s00464-014-3653-0
Antanavicius G, Rezvani M, Sucandy I. One-stage robotically assisted laparoscopic biliopancreatic diversion with duodenal switch: analysis of 179 patients. Surg Obes Relat Dis. 2015;11(2):367–71.
doi: 10.1016/j.soard.2014.10.023
Antanavicius G, Katsichtis T, Alswealmeen W, et al. Three hundred four robotically assisted biliopancreatic diversion with duodenal switch operations with gradual robotic approach implementation: short-term outcomes, complication profile, and lessons learned. Obes Surg. 2020; https://doi.org/10.1007/s11695-020-04764-1 .
Ren CJ, Patterson E, Gagner M. Early results of laparoscopic biliopancreatic diversion with duodenal switch: a case series of 40 consecutive patients. Obes Surg. 2000;10(6):514–23. discussion 524
doi: 10.1381/096089200321593715
Sudan R, Desai S. Conversion of laparoscopic adjustable gastric band to robot-assisted laparoscopic biliopancreatic diversion with duodenal switch. Surg Obes Relat Dis. 2011;7(4):546–7.
doi: 10.1016/j.soard.2011.05.007
Berger E, Clements R, Morton J, et al. The impact of different surgical techniques on outcomes in laparoscopic sleeve gastrectomies: the first report from the metabolic and bariatric surgery accreditation and quality improvement program (MBSAQIP). Ann Surg. 2016;264(3):464–73. https://doi.org/10.1097/SLA.0000000000001851 .
doi: 10.1097/SLA.0000000000001851 pubmed: 27433904
Leepalao M, Arredondo D, Speights F, et al. Same-day discharge on laparoscopic Roux-en-Y gastric bypass patients: an outcomes review. Surg Endosc. 2020;34(8):3614–7. https://doi.org/10.1007/s00464-019-07139-5 .
doi: 10.1007/s00464-019-07139-5 pubmed: 31552506
Armijo P, Pagkratis S, Boilesen E, et al. Growth in robotic-assisted procedures is from conversion of laparoscopic procedures and not from open surgeons’ conversion: a study of trends and costs. Surg Endosc. 2018;32(4):2106–13. https://doi.org/10.1007/s00464-017-5908-z .
doi: 10.1007/s00464-017-5908-z pubmed: 29067582
Arteaga JR, Huerta S, Livingston EH. Management of gastrojejunal anastomotic leaks after Roux-en-Y gastric bypass. Am Surg. 2002;68(12):1061–5.
pubmed: 12516809
Fernandez Jr AZ, DeMaria EJ, Tichansky DS, et al. Experience with over 3,000 open and laparoscopic bariatric procedures: multivariate analysis of factors related to leak and resultant mortality. Surg Endosc. 2004;18(2):193–7.
doi: 10.1007/s00464-003-8926-y
Sebastian R, Howell M, Chang K, et al. Robot-assisted versus laparoscopic Roux-en-Y gastric bypass and sleeve gastrectomy: a propensity score-matched comparative analysis using the 2015–2016 MBSAQIP database. Surg Endosc. 2019;33(5):1600–12. https://doi.org/10.1007/s00464-018-6422-7 .
doi: 10.1007/s00464-018-6422-7 pubmed: 30225604
Moussa O, Ardissino M, Tang A, et al. Long-term impact of bariatric surgery on venous thromboembolic risk: a matched cohort study. Ann Surg. 2019. https://doi.org/10.1097/SLA.0000000000003750 .
Finks JF, English WJ, Carlin AM, et al. Predicting risk for venous thromboembolism with bariatric surgery: results from the Michigan Bariatric Surgery Collaborative. Ann Surg. 2012;255(6):1100–4.
doi: 10.1097/SLA.0b013e31825659d4
Halawani HM, Ripley-Hager CF, Naglak MC, et al. Venous thromboembolism after laparoscopic or robotic biliopancreatic diversion with duodenal switch. Ninety-days outcome of a 10 years’ experience. Surg Obes Relat Dis. 2017;13(12):1984–9.
doi: 10.1016/j.soard.2017.09.002
Moore MD, Afaneh C, Gray KD, et al. The impact of the robotic platform on assistant variability in complex gastrointestinal surgery. J Surg Res. 2017;219:98–102.
doi: 10.1016/j.jss.2017.05.127
Inaba CS, Koh CY, Sujatha-Bhaskar S, et al. Same-day discharge after laparoscopic Roux-en-Y Gastric bypass: an analysis of the metabolic and bariatric surgery accreditation and quality improvement program database. J Am Coll Surg. 2018;226(5):868–73. https://doi.org/10.1016/j.jamcollsurg.2018.01.049 .
doi: 10.1016/j.jamcollsurg.2018.01.049 pubmed: 29428234 pmcid: 6152887
Zevin B, Aggarwal R, Grantcharov TP. Volume-outcome association in bariatric surgery: a systematic review. Ann Surg. 2012;256(1):60–71. https://doi.org/10.1097/SLA.0b013e3182554c62 .
doi: 10.1097/SLA.0b013e3182554c62 pubmed: 22584692

Auteurs

Ahmed M Al-Mazrou (AM)

Division of GI Metabolic and Bariatric Surgery, Department of Surgery, New York-Presbyterian Hospital/Weill Cornell Medicine, 525 East 68th Street Box 294, New York, NY, 10065, USA.

Mariana Vigiola Cruz (MV)

Division of GI Metabolic and Bariatric Surgery, Department of Surgery, New York-Presbyterian Hospital/Weill Cornell Medicine, 525 East 68th Street Box 294, New York, NY, 10065, USA.

Gregory Dakin (G)

Division of GI Metabolic and Bariatric Surgery, Department of Surgery, New York-Presbyterian Hospital/Weill Cornell Medicine, 525 East 68th Street Box 294, New York, NY, 10065, USA.

Omar E Bellorin-Marin (OE)

Division of GI Metabolic and Bariatric Surgery, Department of Surgery, New York-Presbyterian Hospital/Weill Cornell Medicine, 525 East 68th Street Box 294, New York, NY, 10065, USA.

Alfons Pomp (A)

Division of GI Metabolic and Bariatric Surgery, Department of Surgery, New York-Presbyterian Hospital/Weill Cornell Medicine, 525 East 68th Street Box 294, New York, NY, 10065, USA.

Cheguevara Afaneh (C)

Division of GI Metabolic and Bariatric Surgery, Department of Surgery, New York-Presbyterian Hospital/Weill Cornell Medicine, 525 East 68th Street Box 294, New York, NY, 10065, USA. cha9043@med.cornell.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH